PK

Pavan Kumar Balmoori

Active Director Director DIN 10911074
DIN 10911074 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pavan Kumar Balmoori

Data last updated:

Pavan Kumar Balmoori is a Director at Medivour Pharma Private Limited (since 2025). The company operates in Paper.

DIN 10911074
Primary Designation Director
Industry Paper
First Appointment 17 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medivour Pharma Private Limited U21001TS2025PTC193015
Director17 Jan 20252025Active

Board colleagues of Pavan Kumar Balmoori

NameDINCompanyDesignation
Snehalatha Balmuri10911073Medivour Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medivour Pharma Private Limited
Premium access

Shareholding and investment profile for Pavan Kumar Balmoori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavan Kumar Balmoori

Pavan Kumar Balmoori currently holds 1 directorship: Medivour Pharma Private Limited (Director, since 17 Jan 2025).

Pavan Kumar Balmoori was first appointed on 17 Jan 2025 as Director at Medivour Pharma Private Limited.

The current boards of Pavan Kumar Balmoori's companies include Snehalatha Balmuri (Medivour Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available